000 01390 a2200349 4500
005 20250514195156.0
264 0 _c20041108
008 200411s 0 0 eng d
022 _a0160-9289
024 7 _a10.1002/clc.4960270703
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aManoharan, Ganesh
245 0 0 _aConsiderations in combination therapy: fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarction.
_h[electronic resource]
260 _bClinical cardiology
_cJul 2004
300 _a381-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAngioplasty, Balloon, Coronary
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aCoronary Stenosis
_xtherapy
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFibrinolytic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMyocardial Infarction
_xtherapy
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aPlatelet Glycoprotein GPIIb-IIIa Complex
_xantagonists & inhibitors
650 0 4 _aThrombolytic Therapy
650 0 4 _aVascular Patency
_xdrug effects
700 1 _aAdgey, A A Jennifer
773 0 _tClinical cardiology
_gvol. 27
_gno. 7
_gp. 381-6
856 4 0 _uhttps://doi.org/10.1002/clc.4960270703
_zAvailable from publisher's website
999 _c14997856
_d14997856